OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
Sherif Bayoumy, Inge M.W. Verberk, Ben den Dulk, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 140
Sherif Bayoumy, Inge M.W. Verberk, Ben den Dulk, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 140
Showing 1-25 of 140 citing articles:
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
Oskar Hansson, Rebecca M. Edelmayer, Adam L. Boxer, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 12, pp. 2669-2686
Open Access | Times Cited: 355
Oskar Hansson, Rebecca M. Edelmayer, Adam L. Boxer, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 12, pp. 2669-2686
Open Access | Times Cited: 355
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
Shorena Janelidze, Divya Bali, Nicholas J. Ashton, et al.
Brain (2022) Vol. 146, Iss. 4, pp. 1592-1601
Open Access | Times Cited: 280
Shorena Janelidze, Divya Bali, Nicholas J. Ashton, et al.
Brain (2022) Vol. 146, Iss. 4, pp. 1592-1601
Open Access | Times Cited: 280
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials
Rik Ossenkoppele, Rik van der Kant, Oskar Hansson
The Lancet Neurology (2022) Vol. 21, Iss. 8, pp. 726-734
Open Access | Times Cited: 276
Rik Ossenkoppele, Rik van der Kant, Oskar Hansson
The Lancet Neurology (2022) Vol. 21, Iss. 8, pp. 726-734
Open Access | Times Cited: 276
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring
Nicholas J. Ashton, Shorena Janelidze, Niklas Mattsson, et al.
Nature Medicine (2022) Vol. 28, Iss. 12, pp. 2555-2562
Open Access | Times Cited: 245
Nicholas J. Ashton, Shorena Janelidze, Niklas Mattsson, et al.
Nature Medicine (2022) Vol. 28, Iss. 12, pp. 2555-2562
Open Access | Times Cited: 245
Blood biomarkers for Alzheimer’s disease in clinical practice and trials
Oskar Hansson, Kaj Blennow, Henrik Zetterberg, et al.
Nature Aging (2023) Vol. 3, Iss. 5, pp. 506-519
Open Access | Times Cited: 211
Oskar Hansson, Kaj Blennow, Henrik Zetterberg, et al.
Nature Aging (2023) Vol. 3, Iss. 5, pp. 506-519
Open Access | Times Cited: 211
Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility
Thomas K. Karikari, Nicholas J. Ashton, Gunnar Brinkmalm, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 7, pp. 400-418
Closed Access | Times Cited: 208
Thomas K. Karikari, Nicholas J. Ashton, Gunnar Brinkmalm, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 7, pp. 400-418
Closed Access | Times Cited: 208
Plasma and CSF biomarkers in a memory clinic: Head‐to‐head comparison of phosphorylated tau immunoassays
Nicholas J. Ashton, Albert Puig‐Pijoan, Marta Milà‐Alomà, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 5, pp. 1913-1924
Open Access | Times Cited: 134
Nicholas J. Ashton, Albert Puig‐Pijoan, Marta Milà‐Alomà, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 5, pp. 1913-1924
Open Access | Times Cited: 134
Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
Harald Hampel, Yan Hu, Jeffrey L. Cummings, et al.
Neuron (2023) Vol. 111, Iss. 18, pp. 2781-2799
Open Access | Times Cited: 116
Harald Hampel, Yan Hu, Jeffrey L. Cummings, et al.
Neuron (2023) Vol. 111, Iss. 18, pp. 2781-2799
Open Access | Times Cited: 116
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Fernándo González‐Ortiz, Przemysław R. Kac, Wagner S. Brum, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 106
Fernándo González‐Ortiz, Przemysław R. Kac, Wagner S. Brum, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 106
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
Sebastian Palmqvist, Erik Stomrud, Nicholas Cullen, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 4, pp. 1204-1215
Open Access | Times Cited: 95
Sebastian Palmqvist, Erik Stomrud, Nicholas Cullen, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 4, pp. 1204-1215
Open Access | Times Cited: 95
Disease-Modifying Therapies for Alzheimer's Disease: More Questions than Answers
Todd E. Golde
Neurotherapeutics (2022) Vol. 19, Iss. 1, pp. 209-227
Open Access | Times Cited: 82
Todd E. Golde
Neurotherapeutics (2022) Vol. 19, Iss. 1, pp. 209-227
Open Access | Times Cited: 82
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force
Davide Angioni, Julien Delrieu, Oskar Hansson, et al.
The Journal of Prevention of Alzheimer s Disease (2022)
Open Access | Times Cited: 72
Davide Angioni, Julien Delrieu, Oskar Hansson, et al.
The Journal of Prevention of Alzheimer s Disease (2022)
Open Access | Times Cited: 72
Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies
Laia Montoliu‐Gaya, Andréa Lessa Benedet, Cécile Tissot, et al.
Nature Aging (2023) Vol. 3, Iss. 6, pp. 661-669
Open Access | Times Cited: 60
Laia Montoliu‐Gaya, Andréa Lessa Benedet, Cécile Tissot, et al.
Nature Aging (2023) Vol. 3, Iss. 6, pp. 661-669
Open Access | Times Cited: 60
Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges
Suman Dutta, Simon Hornung, Hash Brown Taha, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 5, pp. 515-540
Open Access | Times Cited: 57
Suman Dutta, Simon Hornung, Hash Brown Taha, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 5, pp. 515-540
Open Access | Times Cited: 57
Blood Biomarkers in Neurodegenerative Diseases
Daniel Alcolea, Michal Schnaider Beeri, Julio C. Rojas, et al.
Neurology (2023) Vol. 101, Iss. 4, pp. 172-180
Closed Access | Times Cited: 43
Daniel Alcolea, Michal Schnaider Beeri, Julio C. Rojas, et al.
Neurology (2023) Vol. 101, Iss. 4, pp. 172-180
Closed Access | Times Cited: 43
Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease
Javier Arranz, Nuole Zhu, Sara Rubio‐Guerra, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 31
Javier Arranz, Nuole Zhu, Sara Rubio‐Guerra, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 31
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Burak Arslan, Henrik Zetterberg, Nicholas J. Ashton
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 6, pp. 1063-1069
Open Access | Times Cited: 23
Burak Arslan, Henrik Zetterberg, Nicholas J. Ashton
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 6, pp. 1063-1069
Open Access | Times Cited: 23
Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology
Przemysław R. Kac, Fernándo González‐Ortiz, Andreja Emeršič, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Przemysław R. Kac, Fernándo González‐Ortiz, Andreja Emeršič, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Fully automated measurement of plasma Aβ42/40 and p‐tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts
G. Bellomo, Sherif Bayoumy, Alfredo Megaro, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2453-2468
Open Access | Times Cited: 20
G. Bellomo, Sherif Bayoumy, Alfredo Megaro, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2453-2468
Open Access | Times Cited: 20
Clinical evaluation of a novel plasma pTau217 electrochemiluminescence immunoassay in Alzheimer’s disease
Pia Kivisäkk, Hadia Fatima, Danielle S. Cahoon, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Pia Kivisäkk, Hadia Fatima, Danielle S. Cahoon, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting
Xuemei Zeng, Yijun Chen, Anuradha Sehrawat, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Xuemei Zeng, Yijun Chen, Anuradha Sehrawat, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort
Vincent Planche, Vincent Bouteloup, Isabelle Pellegrin, et al.
Neurology (2022) Vol. 100, Iss. 5
Open Access | Times Cited: 61
Vincent Planche, Vincent Bouteloup, Isabelle Pellegrin, et al.
Neurology (2022) Vol. 100, Iss. 5
Open Access | Times Cited: 61
Current trends in blood biomarker detection and imaging for Alzheimer’s disease
Shun Hu, Changwen Yang, Haiming Luo
Biosensors and Bioelectronics (2022) Vol. 210, pp. 114278-114278
Closed Access | Times Cited: 50
Shun Hu, Changwen Yang, Haiming Luo
Biosensors and Bioelectronics (2022) Vol. 210, pp. 114278-114278
Closed Access | Times Cited: 50
Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease
Przemysław R. Kac, Fernándo González‐Ortiz, Joel Simrén, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 47
Przemysław R. Kac, Fernándo González‐Ortiz, Joel Simrén, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 47
Blood biomarkers for Alzheimer's disease and related disorders
Henrik Zetterberg, Jonathan M. Schott
Acta Neurologica Scandinavica (2022) Vol. 146, Iss. 1, pp. 51-55
Open Access | Times Cited: 39
Henrik Zetterberg, Jonathan M. Schott
Acta Neurologica Scandinavica (2022) Vol. 146, Iss. 1, pp. 51-55
Open Access | Times Cited: 39
